Advertisement

Topics

Cambrex investing $24m in API manufacturing capabilities

11:38 EDT 9 Aug 2017 | Outsourcing-Pharma

Cambrex Corporation is investing $24m in a new facility to manufacture highly potent APIs (HPAPIs).

Original Article: Cambrex investing $24m in API manufacturing capabilities

NEXT ARTICLE

More From BioPortfolio on "Cambrex investing $24m in API manufacturing capabilities"

Quick Search
Advertisement